Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,199 | 9,826 | 18,688 | 13,487 | 9,862 |
| Marketable Securities | 13,240 | 22,872 | 100 | 100 | 1,950 |
| Other current assets | 0 | 0 | 0 | 0 | 19 |
| TOTAL | $24,661 | $33,429 | $19,295 | $13,775 | $12,163 |
| Non-Current Assets | |||||
| PPE Net | 113 | 78 | 65 | 52 | 95 |
| Other Non-Current Assets | 31 | 26 | 196 | 1,092 | 1,432 |
| TOTAL | $144 | $104 | $261 | $1,144 | $1,526 |
| Total Assets | $24,805 | $33,533 | $19,557 | $14,919 | $13,690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,661 | 2,459 | 934 | 852 | 1,185 |
| TOTAL | $2,661 | $2,459 | $934 | $852 | $1,185 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,843 | 3,893 | 5,164 | 2,908 | 973 |
| TOTAL | $3,368 | $4,493 | $5,997 | $4,534 | $1,798 |
| Total Liabilities | $6,030 | $6,953 | $6,931 | $5,385 | $2,984 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 444 | 373 | 368 | 249 | 199 |
| Common Shares | 20 | 18 | 15 | 12 | 10 |
| Retained earnings | -105,717 | -91,332 | -72,811 | -63,311 | -57,085 |
| Other shareholders' equity | -18 | -162 | -28 | -28 | -28 |
| TOTAL | $18,776 | $26,581 | $12,626 | $9,534 | $10,706 |
| Total Liabilities And Equity | $24,805 | $33,533 | $19,557 | $14,919 | $13,690 |